Works matching IS 17407745 AND DT 2023 AND VI 20 AND IP 6

Results: 15

Assessing the use of observational methods and real-world data to emulate ongoing randomized controlled trials.

Published in:

Clinical Trials, 2023, v. 20, n. 6, p. 689, doi. 10.1177/17407745231193137

By:

Wallach, Joshua D;
Deng, Yihong;
Polley, Eric C;
Dhruva, Sanket S;
Herrin, Jeph;
Quinto, Kenneth;
Gandotra, Charu;
Crown, William;
Noseworthy, Peter;
Yao, Xiaoxi;
Jeffery, Molly Moore;
Lyon, Timothy D;
Ross, Joseph S;
McCoy, Rozalina G

Publication type:

Article

Randomized controlled dose-escalation design to evaluate the safety of a novel pharmacological cardiopulmonary resuscitation strategy.

Published in:

Clinical Trials, 2023, v. 20, n. 6, p. 681, doi. 10.1177/17407745231188443

By:

Benson, Sydney;
Yannopoulos, Demetri;
Aufderheide, Tom P;
Murray, Thomas A

Publication type:

Article

Informative cluster size in cluster-randomised trials: A case study from the TRIGGER trial.

Published in:

Clinical Trials, 2023, v. 20, n. 6, p. 661, doi. 10.1177/17407745231186094

By:

Kahan, Brennan C;
Li, Fan;
Blette, Bryan;
Jairath, Vipul;
Copas, Andrew;
Harhay, Michael

Publication type:

Article

Site staff perspectives on communicating trial results to participants: Cost and feasibility results from the Show RESPECT cluster randomised, factorial, mixed-methods trial.

Published in:

Clinical Trials, 2023, v. 20, n. 6, p. 649, doi. 10.1177/17407745231186088

By:

South, Annabelle;
Bailey, Julia;
Bierer, Barbara E;
Burnett, Eva;
Cragg, William J;
Diaz-Montana, Carlos;
Gillies, Katie;
Isaacs, Talia;
Joharatnam-Hogan, Nalinie;
Snowdon, Claire;
Sydes, Matthew R;
Copas, Andrew J

Publication type:

Article

The net benefit for time-to-event outcome in oncology clinical trials with treatment switching.

Published in:

Clinical Trials, 2023, v. 20, n. 6, p. 670, doi. 10.1177/17407745231186081

By:

Fukuda, Musashi;
Sakamaki, Kentaro;
Oba, Koji

Publication type:

Article

A randomized comparison of two-stage versus traditional one-stage consent for a low-stakes randomized trial.

Published in:

Clinical Trials, 2023, v. 20, n. 6, p. 642, doi. 10.1177/17407745231185058

By:

Vickers, Andrew J;
Vertosick, Emily A;
Austria, Mia;
Gaffney, Christopher D;
Carlsson, Sigrid V;
Kim, Scott YH;
Ehdaie, Behfar

Publication type:

Article

Assessing the representativeness of cluster randomized trials: Evidence from two large pragmatic trials in United States nursing homes.

Published in:

Clinical Trials, 2023, v. 20, n. 6, p. 613, doi. 10.1177/17407745231185055

By:

Joyce, Nina R;
Robertson, Sarah E;
McCreedy, Ellen;
Ogarek, Jessica;
Davidson, Edward H;
Mor, Vincent;
Gravenstein, Stefan;
Dahabreh, Issa J

Publication type:

Article

Data monitoring committees in pediatric randomized controlled trials registered in ClinicalTrials.gov.

Published in:

Clinical Trials, 2023, v. 20, n. 6, p. 624, doi. 10.1177/17407745231182417

By:

Machado, Tiago;
Mainoli, Beatrice;
Caldeira, Daniel;
Ferreira, Joaquim J;
Fernandes, Ricardo M

Publication type:

Article

The Targeted Agent and Profiling Utilization Registry Study: A pragmatic clinical trial.

Published in:

Clinical Trials, 2023, v. 20, n. 6, p. 699, doi. 10.1177/17407745231182013

By:

Mangat, Pam K;
Garrett-Mayer, Elizabeth;
Perez, Jacqueline K;
Schilsky, Richard L

Publication type:

Article

Chronic pain trials often exclude people with comorbid depressive symptoms: A secondary analysis of 346 randomized controlled trials.

Published in:

Clinical Trials, 2023, v. 20, n. 6, p. 632, doi. 10.1177/17407745231182010

By:

Cheng, Darren K;
Ullah, Maarij Hannan;
Gage, Henry;
Moineddin, Rahim;
Sud, Abhimanyu

Publication type:

Article

Futility monitoring for randomized clinical trials with non-proportional hazards: An optimal conditional power approach.

Published in:

Clinical Trials, 2023, v. 20, n. 6, p. 603, doi. 10.1177/17407745231181908

By:

Wang, Xiaofei;
George, Stephen L

Publication type:

Article

A comparison of different population-level summary measures for randomised trials with time-to-event outcomes, with a focus on non-inferiority trials.

Published in:

Clinical Trials, 2023, v. 20, n. 6, p. 594, doi. 10.1177/17407745231181907

By:

Quartagno, Matteo;
Morris, Tim P;
Gilbert, Duncan C;
Langley, Ruth E;
Nankivell, Matthew G;
Parmar, Mahesh KB;
White, Ian R

Publication type:

Article

Data-driven strategies for increasing patient diversity in Bristol Myers Squibb–sponsored US oncology clinical trials.

Published in:

Clinical Trials, 2023, v. 20, n. 6, p. 585, doi. 10.1177/17407745231180506

By:

Kuri, Lorena;
Setru, Sagar;
Liu, Gengyuan;
Reed, Diane Moniz;
Weigand, David;
Surampudi, Aparna;
Berger, Susan;
Paulucci, David;
Rai, Angshu;
Sethuraman, Venkat;
Vito, Blythe;
Kellar-Wood, Helen;
Balan, Mariann Micsinai

Publication type:

Article

Poor effort on cognitive testing in voluntary research predicts failure in US Army Ranger School: Implications for clinical trial design.

Published in:

Clinical Trials, 2023, v. 20, n. 6, p. 714, doi. 10.1177/17407745231178847

By:

Turner, Travis H;
Newman, Jill C;
Marriott, Bernadette P

Publication type:

Article

The influence of political ideology on clinical trial knowledge, invitation, and participation among adults in the United States.

Published in:

Clinical Trials, 2023, v. 20, n. 6, p. 708, doi. 10.1177/17407745231178790

By:

Onyeaka, Henry;
Weber, Daniel B;
Chido-Amajuoyi, Onyema;
Muoghalu, Chioma;
Amonoo, Hermioni L

Publication type:

Article